Written by the Nuvirox Research Team
Key Points
- A 12-week randomized trial found MSM significantly improved WOMAC pain, physical function, and quality-of-life scores in adults with knee osteoarthritis compared with placebo.
- Not every trial agrees: an 8-week study in young, physically active military trainees found no significant benefit for preventing knee pain.
- MSM appears to work best as a slow-building option over 8–12 weeks, not a fast-acting one.
Short answer: MSM has real but modest support in adults with existing knee osteoarthritis, though it hasn't shown benefit as a preventive measure in younger, active people. The picture is a mixed one — better evidence in the population it's usually marketed to (older adults with joint pain) than in people just trying to head off pain before it starts.
What is MSM, and why would it affect joints?
Methylsulfonylmethane (MSM) is a naturally occurring organosulfur compound found in small amounts in fruits, vegetables, and grains, and it's a byproduct of dimethyl sulfoxide (DMSO) metabolism. Sulfur is a component of several molecules important to joint tissue, including some of the proteins in cartilage, which is the loose mechanistic basis for testing MSM in osteoarthritis. Its proposed anti-inflammatory action isn't as well characterized at the molecular level as curcumin's or Boswellia's, which is part of why the evidence is more mixed.
Does the dose or population matter?
The two most-cited trials used meaningfully different doses (2 g/day vs. 6 g/day) and meaningfully different populations — one enrolled people 45–90 years old with diagnosed knee OA, the other enrolled 18–40-year-old military trainees without existing joint disease, testing MSM as prevention rather than treatment. That's a real confound when comparing results: it's not necessarily that one trial is 'right' and the other 'wrong', but that MSM may behave differently as a treatment for existing joint pain than as a prophylactic in healthy joints under heavy physical load.
What human studies actually show
Debbi et al., 2011 — 12-week RCT, 49 adults, knee OA. Participants took 3.375 g/day of MSM or placebo. The MSM group showed statistically significant improvements in WOMAC pain, stiffness, and physical function scores, plus better quality-of-life ratings, compared with placebo.1 The authors were candid that this was a relatively small trial and called for larger confirmatory studies — a reasonable caveat given the sample size.
Randomized trial in military initial-entry trainees, 8 weeks. In a very different population — 180 healthy 18–40-year-olds in physically demanding training, without existing knee osteoarthritis — 3 g/day of MSM did not produce significant improvements in knee outcome or mood scores compared with placebo at 30 or 60 days.2 This is the honest counterweight: MSM's positive trials are almost all in older adults with existing joint pain, not as a preventive in young, active populations under heavy training load.
Study Snapshot: Debbi et al., 2011 RCT
| Design | 12-week, randomized, double-blind, placebo-controlled |
| Participants | 49 adults, 45-90 years, radiographically confirmed knee OA |
| Dose | 3.375 g/day MSM (1.125 g three times daily) |
| Primary result | Significant improvement in WOMAC pain, stiffness & function |
| Contrasting trial | 8-week RCT in young military trainees found no benefit |
What MSM won't do
MSM's positive evidence is specifically in people with existing knee osteoarthritis, not as a way to prevent joint pain before it starts — the trial in young, physically active trainees found no benefit for that use case. Like most joint supplements, it takes weeks to show an effect rather than acting immediately. If pain is new, one-sided, accompanied by swelling or warmth, or follows an injury, that calls for a medical evaluation rather than a supplement trial.
What doses were studied
The positive 12-week trial used 3.375 g/day (roughly 1.1 g three times daily). Other trials in the literature have used doses ranging from 1.5 g/day up to 6 g/day, generally for 8–12 weeks before assessing outcomes.
Frequently Asked Questions
Is MSM the same thing as DMSO?
No — MSM is a metabolic breakdown product of DMSO, but it's a distinct, odorless compound typically taken orally, unlike topical DMSO.
How long before MSM might help?
Positive trials generally ran 8–12 weeks before meaningful group differences emerged; shorter trials have been less consistent.
Does MSM work for arthritis prevention, not just treatment?
The best evidence for prevention specifically — in a young, physically active population without existing joint disease — did not show a benefit, so it's not well-supported as a prophylactic.
Are there safety concerns with MSM?
MSM is generally well-tolerated in trials, with mild GI upset the most commonly reported side effect; talk to your doctor if you're pregnant, nursing, or on other medications.
Why did the two main MSM trials disagree so much?
They studied very different things — one tested MSM as a treatment in older adults with diagnosed knee osteoarthritis, the other tested it as prevention in young, healthy trainees under heavy physical training load; a supplement can plausibly help an already-affected joint without preventing strain in a healthy one.
Does MSM have any known drug interactions?
MSM hasn't shown the same documented anticoagulant-interaction pattern seen with glucosamine or bromelain in the research literature, but as with any supplement, mention it to your doctor if you take other medications regularly.
Is MSM sourced naturally or made synthetically?
Commercial MSM supplements are typically produced industrially to achieve a consistent, high-purity dose, even though the compound also occurs naturally in small amounts in some foods; purity and standardization matter more for consistent dosing than the production method itself.
Why do so many joint supplement blends include MSM alongside glucosamine or curcumin?
Because the three ingredients are thought to act through at least partly different mechanisms — MSM's sulfur-related pathway, glucosamine's cartilage-building-block role, and curcumin's anti-inflammatory signaling — formulators often combine them on the theory that different mechanisms might complement each other, though few trials test the specific combinations directly.
Does the source of sulfur in the diet matter, or is MSM special?
MSM is valued as a supplement specifically because it delivers a concentrated, standardized, bioavailable form of organic sulfur, which is harder to guarantee from diet alone given how variable sulfur content is across different foods.
Were the positive MSM trials funded independently or by supplement companies?
Trial funding sources vary across the MSM literature, and it's worth checking a study's funding disclosure alongside its results, as with any nutraceutical research, since industry-funded trials can carry a higher risk of favorable-outcome bias even when methodology is sound.
From Nuvirox
Why we formulated Joint+ Restore
We built Joint+ Restore around the categories of joint-support compounds that show up most consistently in the research above — cartilage-matrix building blocks, plant-derived anti-inflammatories, and enzyme cofactors studied for joint comfort. We're not listing exact ingredients or dosages here because the formula is currently being updated; full label specifics will be posted on the product page once the update is finalized. Every bottle comes with a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
Learn more about Joint+ Restore →The bottom line
Short answer: MSM has real but modest support in adults with existing knee osteoarthritis, though it hasn't shown benefit as a preventive measure in younger, active people. That said, treat this as one input among several when deciding how to approach your own joints, not a substitute for a medical evaluation when something feels genuinely wrong.
References
- Debbi EM, Agar G, Fichman G, et al. Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC Complement Altern Med. 2011;11:50. DOI: 10.1186/1472-6882-11-50. PMID: 21708034.
- Baumgartner NW, et al. A randomized controlled trial evaluating methylsulfonylmethane versus placebo to prevent knee pain in military initial entry trainees. PMID: 29214616.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.